Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6483]

Cancer immunotherapeutics in drug discovery

Cancer immunotherapeutics in drug discovery

'Stem cell' test could identify most aggressive breast cancers

'Stem cell' test could identify most aggressive breast cancers

Leukaemia-associated mutations almost inevitable as we age

Leukaemia-associated mutations almost inevitable as we age

ASCO GU: Early evidence of increase in higher-risk prostate cancers from 2011-2013

ASCO GU: Early evidence of increase in higher-risk prostate cancers from 2011-2013

Pancreatic cancer has four distinct types

Pancreatic cancer has four distinct types

New blood based marker shows potential as general screening tool for cancers

New blood based marker shows potential as general screening tool for cancers

ASCO GU: Men who have had testicular cancer are more likely to develop prostate cancer

ASCO GU: Men who have had testicular cancer are more likely to develop prostate cancer

Important milestone for mCRC patients as first liquid biopsy RAS biomarker testing centre opens

Important milestone for mCRC patients as first liquid biopsy RAS biomarker testing centre opens

Women back idea of more breast screens for those at high risk of cancer

Women back idea of more breast screens for those at high risk of cancer

Launch of the Immuno-Oncology Policy Action Framework

Launch of the Immuno-Oncology Policy Action Framework

More from ecancer